ArticleFood science & nutrition2025
Effects of Omega-3 Fatty Acid Supplementation on Serum Fetuin-A Levels in Patients With Coronary Artery Disease.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of Omega-3 Fatty Acid Supplementation on Serum Fetuin-A Levels in Patients With Coronary Artery Disease.Food science & nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Omega-3 fatty acids (FAs) are being studied as potential regulators of serum fetuin-A, linked to the risk of developing coronary artery disease (CAD). This study aims to assess the impact of omega-3 FA supplementation on the level of serum fetuin-A in patients with CAD. The research was conducted on a sample of 34 male participants between the ages of 35 and 75. These individuals had recently been diagnosed with CAD through the use of conventional coronary angiography. The patients diagnosed with CAD were separated into two groups: the "Omega-3 Group" consisting of 16 individuals, and the "Control Group" consisting of 18 individuals. Both groups were provided with an explanation of the principles of a low-fat diet at the beginning of the study. The patients in the omega-3 group were administered a daily supplementation of 1.560 mg of omega-3 FAs for 8 weeks, whereas the control group did not receive any supplementation. Food consumption was documented through the use of 6-day dietary records. Fetuin-A levels decreased significantly in both the omega-3 and control groups from baseline to Week 8 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.